NCT06858501

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-06-22Est. Completion: 2028-12-20

Enrollment target: 84 participants

Ganglioneuroblastoma, NodularNeuroblastoma

This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care su…

Birmingham, United StatesEst. completion Dec 31, 2029

GanglioneuroblastomaHigh Risk Neuroblastoma

This phase II pilot trial studies the side effects and how well dinutuximab and sargramostim work when combined with che…

Los Angeles, United StatesCompleted Dec 31, 2021

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.